Global burden of CVD: focus on secondary prevention of cardiovascular disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Writing, 2012, Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke), Glob Heart, 7, 297, 10.1016/j.gheart.2012.08.002
Organization WH and UNAIDS, 2007
WHO. WHO. Data and statistics.
Nichols, 2013, Cardiovascular disease in Europe: epidemiological update, Eur Heart J, 34, 3028, 10.1093/eurheartj/eht356
Chung, 2014, Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK, Lancet, 383, 1305, 10.1016/S0140-6736(13)62070-X
Mozaffarian, 2015, American Heart Association Statistics C and Stroke Statistics S. Heart disease and stroke statistics–2015 update: a report from the American Heart Association, Circulation, 131, e29, 10.1161/CIR.0000000000000152
Tuppin, 2009, Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database, Arch Cardiovasc Dis, 102, 279, 10.1016/j.acvd.2009.02.005
Andres, 2012, Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study, Rev Esp Cardiol (Engl Ed), 65, 414
Bischoff, 2006, Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany, Clin Res Cardiol, 95, 405, 10.1007/s00392-006-0399-2
Stranges E, Barrett M, Wier LM and Andrews RM. Readmissions for heart attack, 2009. 2012.
Koch, 2015, Increasing prevalence despite decreasing incidence of ischaemic heart disease and myocardial infarction. A national register based perspective in Denmark, 1980-2009, Eur J Prev Cardiol, 22, 189, 10.1177/2047487313509495
Smolina, 2012, Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study, Eur J Public Health, 22, 848, 10.1093/eurpub/ckr196
Smolina, 2012, Long-term survival and recurrence after acute myocardial infarction in England, 2004 to 2010, Circ Cardiovasc Qual Outcomes, 5, 532, 10.1161/CIRCOUTCOMES.111.964700
Alwan, 2011
Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, Bmj, 338
Antithrombotic Trialists, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative metaanalysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1
Cholesterol Treatment Trialists, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5
Perk, 2012, European Guidelines on cardiovascular disease prevention in clinical practice (version 2012), European heart journal, 33, 1635, 10.1093/eurheartj/ehs092
Stone, 2014, ACC/AHA Cholesterol Guideline Panel. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline, Ann Intern Med, 160, 339, 10.7326/M14-0126
Kotseva, 2009, Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, Lancet, 373, 929, 10.1016/S0140-6736(09)60330-5
Yusuf, 2011, Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey, Lancet, 378, 1231, 10.1016/S0140-6736(11)61215-4
Zeymer, 2013, Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR), Int J Cardiol, 170, 239, 10.1016/j.ijcard.2013.10.057
Lafeber, 2013, The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus, Eur J Prev Cardiol, 20, 771, 10.1177/2047487312449587
Muntner, 2011, Projected impact of polypill use among US adults: medication use, cardiovascular risk reduction, and side effects, American heart journal, 161, 719, 10.1016/j.ahj.2010.12.019
Mendis, 2005, WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHOPREMISE), Bull World Health Organ, 83, 820
Accessibility PD. Issues in International Health Policy. 2010.
Haynes, 1996, Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications, Lancet, 348, 383, 10.1016/S0140-6736(96)01073-2
O'Flaherty, 2013, Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s?, Heart, 99, 159, 10.1136/heartjnl-2012-302300
Naderi, 2012, Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients, Am J Med, 125, 882, 10.1016/j.amjmed.2011.12.013
Chowdhury, 2013, Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences, Eur Heart J, 34, 2940, 10.1093/eurheartj/eht295
Sabaté, 2003
Castellano, 2014, A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality, J Am Coll Cardiol, 64, 613, 10.1016/j.jacc.2014.06.009
Perreault, 2005, Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention, Br J Clin Pharmacol, 59, 564, 10.1111/j.1365-2125.2005.02355.x
Kassab, 2013, Patients’ adherence to secondary prevention pharmacotherapy after acute coronary syndromes, Int J Clin Pharm, 35, 275, 10.1007/s11096-012-9735-y
Castellano, 2014, A polypill strategy to improve adherence: results from the FOCUS project, J Am Coll Cardiol, 64, 2071, 10.1016/j.jacc.2014.08.021
Choudhry, 2008, Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients, Pharmacoepidem Dr S, 17, 1189, 10.1002/pds.1671
Akincigil, 2008, Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction, J Gen Intern Med, 23, 115, 10.1007/s11606-007-0351-9
Ens, 2014, South Asians’ cardiac medication adherence, Eur J Cardiovasc Nurs, 13, 357, 10.1177/1474515113498187
Ho, 2008, Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease, American heart journal, 155, 772, 10.1016/j.ahj.2007.12.011
Dagenais, 2006, Angiotensin-convertingenzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials, The Lancet, 368, 581, 10.1016/S0140-6736(06)69201-5
Mukherjee, 2004, Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes, Circulation, 109, 745, 10.1161/01.CIR.0000112577.69066.CB
Newby, 2006, Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease, Circulation, 113, 203, 10.1161/CIRCULATIONAHA.105.505636
Taylor, 2007, Acute coronary syndromes in Europe: 1-year costs and outcomes, Current Medical Research and Opinion®, 23, 495, 10.1185/030079906X167462
Bitton, 2013, The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review, Am J Med, 126, 357, 10.1016/j.amjmed.2012.09.004
Heeley, 2009, Role of health insurance in averting economic hardship in families after acute stroke in China, Stroke, 40, 2149, 10.1161/STROKEAHA.108.540054
Marcum, 2013, Medication nonadherence: a diag-nosable and treatable medical condition, JAMA, 309, 2105, 10.1001/jama.2013.4638
Mwaka, 2013, Mind the gaps: a qualitative study of perceptions of healthcare professionals on challenges and proposed remedies for cervical cancer help-seeking in post conflict northern Uganda, BMC family practice, 14, 193, 10.1186/1471-2296-14-193
Choudhry, 2015, Rationale and design of the Randomized Evaluation to Measure Improvements in Non-adherence from Low-Cost Devices (REMIND) trial, Contemporary clinical trials, 43, 53, 10.1016/j.cct.2015.05.006
Castellano, 2014, Evolution of the polypill concept and ongoing clinical trials, Canadian Journal of Cardiology, 30, 520, 10.1016/j.cjca.2014.02.016
Castellano, 2014, A polypill strategy to improve adherence: results from the FOCUS project, Journal of the American College of Cardiology, 64, 2071, 10.1016/j.jacc.2014.08.021
Berben, 2011, Which interventions are used by health care professionals to enhance medication adherence in cardiovascular patients? A survey of current clinical practice, European Journal of Cardiovascular Nursing, 10, 14, 10.1016/j.ejcnurse.2010.10.004
Nieuwkerk, 2012, Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk, The American journal of cardiology, 110, 666, 10.1016/j.amjcard.2012.04.045
Hohmann, 2013, Adherence to hospital discharge medication in patients with ischemic stroke A prospective, interventional 2phase study, Stroke, 44, 522, 10.1161/STROKEAHA.112.678847
Kalichman, 2010, Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS, Psychosomatic medicine, 72, 810, 10.1097/PSY.0b013e3181f01be3
Parashar, 2011, Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed, AIDS and Behavior, 15, 1612, 10.1007/s10461-011-0026-8
Nieuwlaat, 2014, Interventions for enhancing medication adherence, Cochrane Database Syst Rev, 11
Eurostat. Database -Eurostat.